New wave medicine: The clinical potential of non-hallucinogenic “designer psychedelics”
Sofia Luchanskaya discusses the clinical potential of psychedelics in treating mood and addiction disorders.
Sofia Luchanskaya discusses the clinical potential of psychedelics in treating mood and addiction disorders.
Alice Pebody reports on a novel use of AI, screening chemical libraries for antibiotic candidates against MRSA.
Isabel Schmidt discusses why larger animals do not show an increased cancer rate that is expected given their size.
Connor Forsyth discusses the recent explorations into the lung microbiome, and its role in treatment for cancer.
Isabella Farrance reports the use of fosravuconazole for treating Mycetoma, and the social factors that may hinder its deployment.
George Rabin discusses new research suggesting that human-to-human mpox transmission began in 2016 at the latest, prior to the 2022 outbreak.
Laura Santamaria Perez explores the way pathogens mimic human biology to disguise themselves from the immune system.
Alice Pebody explores the triumphs of xenotransplantation and discusses what this could mean for xenotransplantation in human therapeutics.
Ayaka Hogg delves into Rabies, a disease of terror, and how a virus strikes the fear of wind and water into the hearts of those infected.
George Rabin reports on the first instance of Avian Influenza detected in the Antarctic, posing threats to vulnerable and endangered species.